Income Statement
ENVOY MEDICAL, INC.
COCH
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
0.24 | 0.23 | 0.32 | - | - |
|
Cost of Revenue
|
0.87 | 0.74 | 0.79 | - | - |
|
Gross Profit
|
-0.63 | -0.52 | -0.47 | - | - |
|
Operating Expenses
|
20.42 | 17.01 | 16.23 | 4.89 | 5.20 |
|
Research & Development
|
12.49 | 10.18 | 8.96 | - | - |
|
Selling, General & Administrative
|
7.93 | 6.83 | 7.28 | - | - |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-21.05 | -17.52 | -16.71 | -4.89 | -5.20 |
|
Non-Operating Income
|
-1.49 | -1.54 | -11.54 | -25.62 | - |
|
Interest Income
|
- | - | - | 6.13 | 0.04 |
|
Interest Expense
|
1.59 | - | - | - | - |
|
Other Non-Op Income / Expense
|
-0.02 | -0.03 | 0.08 | - | - |
|
Income Before Tax
|
-23.76 | - | - | 20.74 | - |
|
Income Tax Expense
|
- | - | - | 1.50 | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-23.76 | -20.80 | 29.91 | 19.23 | -0.25 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-21.05 | -17.52 | -16.71 | -4.89 | -5.20 |
|
Earnings Per Share (Basic)
|
-1.23 | -1.49 | -2.38 | 0.36 | -0.01 |
|
Diluted EPS
|
-1.23 | -1.49 | -2.38 | 0.36 | -0.01 |
|
Weighted Average Shares
|
23.26 | 18.79 | 12.55 | 42.50 | 35.22 |
|
Diluted Weighted Avg Shares
|
23.26 | 18.79 | 12.55 | 42.50 | 35.22 |
|
Comprehensive Income
|
-23.75 | -20.80 | -29.91 | - | - |